Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, and welcome to Agios’ Fourth Quarter 2024 ...

Terumo Corporation ( OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ET [Call Starts Abruptly] Thank you for your kind introduction. I’m Hagimoto, Terumo’s CFO. This ...

Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings – the Transplantation & Cellular Therapy ...

Blood-based MRD testing grew 55% and contributed ... Our goal is to discover and develop antibodies that deplete or block the autoreactive T cell receptors that are causing disease. As shown on slide ...

Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Gustav Klimt attended discussions of scientific developments, like the microscope, which he incorporated into his work ...

Amicus is focused on delivering significant long-term revenue growth and anticipates surpassing $1 billion in total sales in 2028. The Company anticipates continuing to grow its current commercial ...

Total Revenue of $528.3M, a 33% Increase Year-over-Year Projecting 2025 Total Revenue Growth of 17-24% at CER Anticipate Achieving Positive GAAP Net Income During H2 2025 Conference Call and Webcast ...

I thought I was on the road to recovery but when I was told I needed a second operation I was nervous, as pulling the ...